Percutaneous coronary intervention with implantation of drug-eluting stents (DES) has reduced the need for repeat revascularisation compared with bare-metal stents (BMS).1 However, first-generation DES with durable polymers were associated with a slightly increased risk of stent thrombosis, especially very late stent thrombosis after discontinuation of dual antiplatelet therapy.2,3 New-generation DES have therefore been developed to improve safety.
Original Article: [Comment] Are drug-eluting stents safer than bare-metal stents?